5 Key Takeaways | Best Practices in Patent Drafting: Addressing 112 and Enablement after Amgen
A recent post-grant review decision once again reminds patentees of the increasing scrutiny that claims are facing under the written description and enablement requirements under 35 U.S.C. § 112 (a). In this case,...more